🙏 A big thank you to the Universitat Politècnica de Catalunya (UPC) members for this very nice article on the progress of our PERMEPSY project!
👏 Read here: https://lnkd.in/eEZYU3dy
🎯 As a reminder, one of the main objectives of PERMEPSY is to develop a predictive platform for the effectiveness of Metacognitive Training (MCT) for psychosis (Steffen Moritz), which will be freely accessible.
📊 As announced in the article, the predictive platform is powered by previous RCTs on MCT for psychosis, involving over 700 participants.
🔬The platform will soon be tested in a pilot clinical trial involving 250 people with #schizophrenia across 🇪🇸Spain, 🇩🇪Germany, 🇵🇱Poland, 🇫🇷France, and 🇨🇱Chile.
📝We will, of course, keep you informed of progress. In the meantime, we hope that we will soon be able to share with you the literature reviews and meta-analyses on MCT written by our team, which are currently under review.
📢Stay tuned!
🎉 Research is about to start at Wolski and Bielanski Hospitals in Warsaw! 🎉
🧠 As part of this study, we will offer patients #MCT (Metacognitive Training) to help them develop their metacognitive skills. 👉 Preparations are in the
2025-01-14
